longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Basel Medical

BMGL

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 FY2026 Earnings

Financial report interval: 2025.10.01 - 2025.12.31

Overview: Basel Medical(BMGL) the Revenue is 3.278 M (+76.98%);the EBIT is -1.076 M (-413.8%);the EPS is 0.067 (+177.8%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B76.98%
----
----
EBIT
-0.00B413.81%
----
----
EPS
0.067177.84%
----
----

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf